CD34 and myelodysplastic syndrome: Myelodysplastic syndromes (MDS) and acute myeloid leukaemia (AML) are characterised by abnormal differentiation of bone marrow haematopoietic stem cells (HSCs) into immature CD34+ blast cells and ineffective haematopoiesis [1].